| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.040 | 1.423 | 1.534 | 1.887 | 1.401 | 839 | 667 | 1.162 | 1.605 | 1.902 |
| Total Income - EUR | 2.040 | 1.423 | 1.534 | 1.887 | 1.401 | 839 | 667 | 1.162 | 1.605 | 1.902 |
| Total Expenses - EUR | 1.667 | 1.411 | 1.440 | 1.749 | 1.413 | 1.025 | 744 | 1.003 | 783 | 976 |
| Gross Profit/Loss - EUR | 373 | 12 | 93 | 138 | -11 | -185 | -77 | 159 | 822 | 925 |
| Net Profit/Loss - EUR | 312 | -30 | 47 | 86 | -54 | -208 | -97 | 124 | 751 | 780 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Medoptic Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 49 | 70 | 19 | 234 | 172 | 115 | 149 | 281 | 1.045 | 1.840 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 49 | 70 | 19 | 234 | 172 | 115 | 149 | 281 | 1.045 | 1.840 |
| Shareholders Funds | -1.084 | -1.104 | -1.038 | -932 | -968 | -1.158 | -1.229 | -1.109 | -354 | 428 |
| Social Capital | 112 | 111 | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | 1.133 | 1.174 | 1.056 | 1.166 | 1.140 | 1.273 | 1.378 | 1.390 | 1.399 | 1.412 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Medoptic Srl